Researchers at the Western College of Veterinary Medicine (WCVM) are seeking canine patients for two radiation oncology clinical trials. If you have a dog that may be a potential candidate for one of these studies, please share this information with your veterinarian or contact Dr. Monique Mayer for more information.
Oral melanoma
Oral melanoma is the most common malignant oral tumour diagnosed in dogs, with a high risk of distant metastasis. The objective of the first clinical trial is to determine whether PET-CT (positron emission tomography-computed tomography) technology provides more accurate staging information than computed tomography (CT) alone for dogs with oral melanoma.
- Tumour type: Oral melanoma
- Species: Dog
- Inclusion: Gross disease, no prior radiation therapy or chemotherapy
- Study pays for: PET-CT, MRI, immobilization, $500 toward invoice
- Contact: Dr. Monique Mayer (monique.mayer@usask.ca)
Mast cell tumour
Mast cell tumour is a common cutaneous tumour diagnosed in dogs, with a risk of metastasis to the draining lymph nodes. The objective of the second trial is to determine whether PET-CT (positron emission tomography-computed tomography) technology adds to our ability to diagnose early metastasis to the lymph nodes draining the primary tumour.
- Tumor type: Mast cell tumour
- Species: Dog
- Inclusion: Gross disease, no prior radiation therapy or chemotherapy
- Study pays for: PET-CT, regional lymph node surgical removal, regional lymph node histopathology
- Contact: Dr. Alison Williams (alison.williams@usask.ca) or Dr. Monique Mayer (monique.mayer@usask.ca).
Contact information
Dr. Monique Mayer, DVM, MSc, DACVR (Radiation Oncology)
monique.mayer@usask.ca